BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28787279)

  • 21. Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications.
    Kommoss FK; Chang KT; Stichel D; Banito A; Jones DT; Heilig CE; Fröhling S; Sahm F; Stenzinger A; Hartmann W; Mechtersheimer G; Sinn HP; Schmidt D; Kommoss F; von Deimling A; Koelsche C
    J Pathol Clin Res; 2020 Jul; 6(3):178-184. PubMed ID: 32352245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial stromal tumors: the new WHO classification.
    Conklin CM; Longacre TA
    Adv Anat Pathol; 2014 Nov; 21(6):383-93. PubMed ID: 25299308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory myofibroblastic tumor of the uterus with prominent myxoid change.
    Shintaku M; Fukushima A
    Pathol Int; 2006 Oct; 56(10):625-8. PubMed ID: 16984620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
    Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
    Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
    Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
    Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.
    Agaimy A; Clarke BA; Kolin DL; Lee CH; Lee JC; McCluggage WG; Pöschke P; Stoehr R; Swanson D; Turashvili G; Beckmann MW; Hartmann A; Antonescu CR; Dickson BC
    Am J Surg Pathol; 2022 Sep; 46(9):1298-1308. PubMed ID: 35575789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.
    Arias-Stella JA; Benayed R; Oliva E; Young RH; Hoang LN; Lee CH; Jungbluth AA; Frosina D; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 Mar; 43(3):382-388. PubMed ID: 30489320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.
    Hoang L; Chiang S; Lee CH
    Pathology; 2018 Feb; 50(2):162-177. PubMed ID: 29275929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZC3H7B-BCOR high-grade endometrial stromal sarcoma may present as myoma nascens with cytoplasmic signet ring cell change.
    Ondič O; Bednářová B; Ptáková N; Hájková V; Šteiner P; Šidlová H; Presl J; Bouda J; Alaghehbandan R; Michal M
    Virchows Arch; 2020 Apr; 476(4):615-619. PubMed ID: 31938824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
    Oliva E; Clement PB; Young RH
    Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
    Fong A; Offman S
    Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
    Lu B; Shi H; Zhang X
    Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine epithelioid leiomyosarcoma with c-kit expression and YWHAE gene rearrangement: a case report of a diagnostic pitfall of uterine sarcoma.
    Kubo T; Sugita S; Wada R; Kikuchi N; Iwasaki M; Ito Y; Sugawara T; Fujita H; Emori M; Tanaka R; Hirano H; Saito T; Hasegawa T
    Diagn Pathol; 2017 Mar; 12(1):26. PubMed ID: 28288693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With
    Ling F; Ruan S; Chen H; Xiong X; Zhao D; Haybaeck J; Zhang C
    In Vivo; 2022; 36(4):1971-1976. PubMed ID: 35738637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZC3H7B-BCOR-Rearranged Endometrial Stromal Sarcomas: A Distinct Subset Merits its Own Classification?
    Mansor S; Kuick CH; Lim SL; Quek R; Wong APC; Lim-Tan SK; Lim TYK; Chang KTE
    Int J Gynecol Pathol; 2019 Sep; 38(5):420-425. PubMed ID: 29901520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial stromal tumours revisited: an update based on the 2014 WHO classification.
    Ali RH; Rouzbahman M
    J Clin Pathol; 2015 May; 68(5):325-32. PubMed ID: 25595274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characteristics of uterine sarcomas.
    Davidson B; Micci F
    Expert Rev Mol Diagn; 2017 May; 17(5):515-522. PubMed ID: 28335657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.
    Schaefer IM; Hornick JL; Sholl LM; Quade BJ; Nucci MR; Parra-Herran C
    Histopathology; 2017 Jun; 70(7):1138-1146. PubMed ID: 28130839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.